NORTHERN TRUST CORP - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 66 filers reported holding HUMACYTE INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$1,519,457
+6.3%
518,586
+3.7%
0.00%
Q2 2023$1,430,023
-4.7%
500,008
+2.9%
0.00%
Q1 2023$1,501,236
+39.5%
485,837
-4.7%
0.00%
Q4 2022$1,075,894
+39.9%
509,902
+116.4%
0.00%
Q3 2022$769,000
-1.0%
235,642
-2.8%
0.00%
Q2 2022$777,000
-9.9%
242,389
+98.5%
0.00%
Q1 2022$862,000
-4.3%
122,089
-1.8%
0.00%
Q4 2021$901,000124,3760.00%
Other shareholders
HUMACYTE INC shareholders Q4 2021
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,177,0004.71%
Endowment Wealth Management, Inc. 96,618$682,0000.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 36,171$255,0000.24%
Prescott General Partners LLC 625,100$4,413,0000.20%
CenterBook Partners LP 45,752$323,0000.12%
Gladstone Institutional Advisory LLC 144,867$1,0230.07%
Exos Asset Management LLC 18,609$131,0000.06%
Sciencast Management LP 26,300$182,0000.04%
Y-Intercept (Hong Kong) Ltd 17,125$121,0000.03%
Kovack Advisors, Inc. 31,500$222,0000.02%
View complete list of HUMACYTE INC shareholders